Pharmacologic management of diabetic peripheral neuropathic pain

Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey

(2013) Alesia Sadosky et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Management of Painful Diabetic Neuropathy: Guideline Guidance or Jungle?

(2012) Vincenza Spallone   Current Diabetes Reports

Opioids before and after initiation of pregabalin in patients with diabetic peripheral neuropathy

(2012) Chris M. Kozma et al.   CURRENT MEDICAL RESEARCH AND OPINION

Rab7 Silencing Prevents  -Opioid Receptor Lysosomal Targeting and Rescues Opioid Responsiveness to Strengthen Diabetic Neuropathic Pain Therapy

(2012) S. A. Mousa et al.   DIABETES

Diabetic neuropathy: clinical manifestations and current treatments

(2012) Brian C Callaghan et al.   LANCET NEUROLOGY

Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy

(2012) Claudia M. Campbell et al.   PAIN

Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy

(2012) David Yarnitsky et al.   PAIN

Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the U.K.

(2011) C. A. Abbott et al.   DIABETES CARE

IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030

(2011) David R. Whiting et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management

(2011) S. Tesfaye et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

The adverse event profile of pregabalin: A systematic review and meta-analysis of randomized controlled trials

(2011) Gaetano Zaccara et al.   EPILEPSIA

Duloxetine, Pregabalin, and Duloxetine Plus Gabapentin for Diabetic Peripheral Neuropathic Pain Management in Patients With Inadequate Pain Response to Gabapentin: An Open-Label, Randomized, Noninferiority Comparison

(2011) Robert J. Tanenberg et al.   MAYO CLINIC PROCEEDINGS

Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation

(2011) V. Bril et al.   NEUROLOGY

Sustained-Release Oxycodone Tablets for Moderate to Severe Painful Diabetic Peripheral Neuropathy: A Multicenter, Open-Labeled, Postmarketing Clinical Observation

(2011) Peng Yao et al.   PAIN MEDICINE

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

(2010) N. Attal et al.   EUROPEAN JOURNAL OF NEUROLOGY

Painful Diabetic Neuropathy: Advantage of novel drugs over old drugs?

(2009) D. Ziegler   DIABETES CARE

Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review

(2009) Kate E. Schemmel et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use

(2009) S. Swaroop Vedula et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diabetes and the peripheral nerve

(2008) Irina G. Obrosova   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Relationship Between Risk Factors and Mortality in Type 1 Diabetic Patients in Europe: The EURODIAB Prospective Complications Study (PCS)

(2008) S. S. Soedamah-Muthu et al.   DIABETES CARE

Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral Neuropathy: Findings from seven randomized, controlled trials across a range of doses

(2008) R. Freeman et al.   DIABETES CARE

Diabetic neuropathy: Mechanisms to management

(2008) James L. Edwards et al.   PHARMACOLOGY & THERAPEUTICS

Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: A randomized, double-blind study

(2007) Thomas Tölle et al.   EUROPEAN JOURNAL OF PAIN